---
figid: PMC5297839__ijms-18-00210-g001
figlink: /pmc/articles/PMC5297839/figure/ijms-18-00210-f001/
number: F1
caption: 'The phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR),
  retrovirus-associated DNA sequences/mitogen activated protein kinase (RAS/MAPK)
  pathways and c-MYC are master regulators of cell growth and proliferation. The PI3K/mTOR
  and RAS/MAPK signalling, and c-MYC transcription pathways are three major oncogenic
  drivers of cell growth and proliferation. They form a “super” network to regulate
  ribosome biogenesis and protein translation. The signalling cascades are predominantly
  initiated upon growth factor stimulation through receptor tyrosine kinases. Growth
  factors are represented by the green square and yellow circle. Activation of PI3K
  leads to induction of downstream effects mediated by the AKT oncoprotein including
  the activation of mTORC1 and subsequent phosphorylation of its downstream effectors,
  4E-BP1 and p70S6K1. Concomitantly, the RAS signalling pathway and the c-MYC transcription
  factor contribute to the control of ribosome biogenesis via modulating the synthesis
  of rRNAs by Pol I. Moreover, c-MYC also exerts its positive regulatory effects on
  Pol II, Pol III, and eIF4E. Together, these three key pathways promote ribosome
  synthesis and protein synthesis and thus cell growth. (PI3K: phosphatidylinositol-3-kinase;
  mTORC: mammalian target of rapamycin complex; PTEN: phosphatase and tensin homolog;
  PIP2: phosphatidylinositol-4,5-bisphosphate; PIP3: phosphatidylinositol-3,4,5-triphosphate;
  p70S6K1: p70 S6 kinase 1; 4E-BP1: eukaryotic initiation factor 4E-binding protein
  1; eIF4E: eukaryotic translation initiation factor 4E; rRNA: ribosomal RNA; Pol
  I: RNA Polymerase I; Pol II: RNA Polymerase II; Pol III: RNA Polymerase III). The
  grey arrows denote ongoing transcription.'
pmcid: PMC5297839
papertitle: The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian
  Cancer.
reftext: Shunfei Yan, et al. Int J Mol Sci. 2017 Jan;18(1):210.
pmc_ranked_result_index: '22344'
pathway_score: 0.9702074
filename: ijms-18-00210-g001.jpg
figtitle: Phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR),
  retrovirus-associated DNA sequences/mitogen activated protein kinase (RAS/MAPK)
  pathways and c-MYC are master regulators of cell growth and proliferation
year: '2017'
organisms:
- Homo sapiens
ndex: 8ccb2417-dec8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5297839__ijms-18-00210-g001.html
  '@type': Dataset
  description: 'The phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR),
    retrovirus-associated DNA sequences/mitogen activated protein kinase (RAS/MAPK)
    pathways and c-MYC are master regulators of cell growth and proliferation. The
    PI3K/mTOR and RAS/MAPK signalling, and c-MYC transcription pathways are three
    major oncogenic drivers of cell growth and proliferation. They form a “super”
    network to regulate ribosome biogenesis and protein translation. The signalling
    cascades are predominantly initiated upon growth factor stimulation through receptor
    tyrosine kinases. Growth factors are represented by the green square and yellow
    circle. Activation of PI3K leads to induction of downstream effects mediated by
    the AKT oncoprotein including the activation of mTORC1 and subsequent phosphorylation
    of its downstream effectors, 4E-BP1 and p70S6K1. Concomitantly, the RAS signalling
    pathway and the c-MYC transcription factor contribute to the control of ribosome
    biogenesis via modulating the synthesis of rRNAs by Pol I. Moreover, c-MYC also
    exerts its positive regulatory effects on Pol II, Pol III, and eIF4E. Together,
    these three key pathways promote ribosome synthesis and protein synthesis and
    thus cell growth. (PI3K: phosphatidylinositol-3-kinase; mTORC: mammalian target
    of rapamycin complex; PTEN: phosphatase and tensin homolog; PIP2: phosphatidylinositol-4,5-bisphosphate;
    PIP3: phosphatidylinositol-3,4,5-triphosphate; p70S6K1: p70 S6 kinase 1; 4E-BP1:
    eukaryotic initiation factor 4E-binding protein 1; eIF4E: eukaryotic translation
    initiation factor 4E; rRNA: ribosomal RNA; Pol I: RNA Polymerase I; Pol II: RNA
    Polymerase II; Pol III: RNA Polymerase III). The grey arrows denote ongoing transcription.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK9
  - MAPK12
  - MAP2K2
  - MAPK10
  - MAPK11
  - MLST8
  - MAPK13
  - MAP2K1
  - PIK3R4
  - PIK3CA
  - PIK3R6
  - MAPK8
  - BRAF
  - HRAS
  - PIK3CB
  - PIK3R5
  - RPS6
  - PIK3CD
  - KRAS
  - NRAS
  - MAPK3
  - MAPK1
  - MAPK14
  - MTOR
  - RICTOR
  - RAF1
  - EIF4EBP1
  - PIK3CG
  - ARAF
  - PIK3R3
  - RPTOR
  - MAPKAP1
  - MYC
  - AKT1
  - PTEN
  - AKT3
  - POLI
  - AKT2
  - tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RPS6
  symbol: RPS6
  source: hgnc_symbol
  hgnc_symbol: RPS6
  entrez: '6194'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: c-MYC
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PolI)
  symbol: POLI
  source: hgnc_symbol
  hgnc_symbol: POLI
  entrez: '11201'
- word: '>c-MYC)'
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals:
- word: tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5297839__F1
redirect_from: /figures/PMC5297839__F1
figtype: Figure
---
